What is the Impact Factor of Uspehi Molekularnoj Onkologii?

The journal Uspehi Molekularnoj Onkologii is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Uspehi Molekularnoj Onkologii indexed in Web of Science or Scopus?

Yes, Uspehi Molekularnoj Onkologii is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.126 (Q4) and an H-index of 4.

Who publishes Uspehi Molekularnoj Onkologii and what is the Article Processing Charge (APC)?

Uspehi Molekularnoj Onkologii is published by ABC-press Publishing House. It operates under a Diamond Open Access model, exempting authors completely from Article Processing Charges ($0 USD APC).

WoS SCIE Q1Scopus Q4SCImago #27,693Diamond OADiamond OA

Uspehi Molekularnoj Onkologii

Identifier (ISSN):2313-805X(Print)/2413-3787(Online)

•

Publisher:ABC-press Publishing House

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Uspehi Molekularnoj Onkologii

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & RankScopus Q4

0.126

#27,693

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

4 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessDiamond OA

9articles/year

0% Gold OA•0% Original Research

Aims & Scope

Uspehi Molekularnoj Onkologii (ISSN: 2313-805X) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by ABC-press Publishing House in Russian Federation. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.126 (Q4), an H-index of 4.

Topics Covered (Recognized by AI)

BiologyGeneticsMedicineChemistryInternal MedicineBiochemistryOncology & Cancer ResearchCancer ResearchPathologyImmunologyCell BiologyOncology

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics Toxicology and Pharmaceutics (miscellaneous)

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF—

Articles / Year9

Total Citations0

2025

IF0

Articles / Year43

Total Citations7

2024

IF—

Articles / Year41

Total Citations39

2023

IF—

Articles / Year47

Total Citations48

2022

IF—

Articles / Year41

Total Citations44

Year	Impact Factor	Articles / Year	Total Citations
2026	—	9	0
2025	0	43	7
2024	—	41	39
2023	—	47	48
2022	—	41	44
2021	—	36	68
2020	—	21	36
2019	—	43	72
2018	—	26	59
2017	—	34	81
2016	—	23	63
2015	—	42	75

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #27,693Scopus Q4Diamond OASCImago Profile

Scopus Coverage:2019-2025

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q4

0.126

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

0.27

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations31

3-Year Documents118

Citable Documents118

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate63.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry (medical)Q4

Cancer ResearchQ4

Genetics (clinical)Q4

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 9 scientific articles. In terms of accessibility and author fees, it operates under the Diamond OA model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.